Latest Articles
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily
Published: April 18, 2026, 6:23 p.m.
Lena Dunham and the art monster - New Statesman
Lena Dunham and the art monster New Statesman
Published: April 18, 2026, 1:36 a.m.
Famesick review: Lena Dunham, art monster - New Statesman
Famesick review: Lena Dunham, art monster New Statesman
Published: April 18, 2026, 1:30 a.m.
ACOG updates guidance for evaluating postmenopausal bleeding - Contemporary OB/GYN
ACOG updates guidance for evaluating postmenopausal bleeding Contemporary OB/GYN
Published: April 17, 2026, 7:46 p.m.
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today
Published: April 16, 2026, 7:11 p.m.
'Non-invasive' womb cancer test could be rolled out - AOL.com
'Non-invasive' womb cancer test could be rolled out AOL.com
Published: April 16, 2026, 11:50 a.m.
Breaking taboos Vital group offers advice and support for ostomates | Bristol Post - newspaper - Magzter
Breaking taboos Vital group offers advice and support for ostomates | Bristol Post - newspaper Magzter
Published: April 16, 2026, 9:55 a.m.
Endometrial Cancer Staging Updates Reflect Molecular Profiling - Cleveland Clinic
Endometrial Cancer Staging Updates Reflect Molecular Profiling Cleveland Clinic
Published: April 16, 2026, 5:42 a.m.
SimonMed collaborates with women's health AI company to improve MRI diagnoses - Radiology Business
SimonMed collaborates with women's health AI company to improve MRI diagnoses Radiology Business
Published: April 15, 2026, 9:27 p.m.
Ramu Perni, MD, MBA, on red blood cell fetal antigen prenatal tests - Contemporary OB/GYN
Ramu Perni, MD, MBA, on red blood cell fetal antigen prenatal tests Contemporary OB/GYN
Published: April 13, 2026, 11:47 p.m.
Link copied to clipboard!